2015.01.09,我院田志刚教授研究组在J Hepatol在线发表题为:“Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice”的研究论文

时间:2021-04-12 21:10:02学院:生命科学学院学校:中国科学技术大学
作 者:Cui K, Yan G, Xu C, Chen Y, Wang J, Zhou R, Bai L, Lian Z, Wei H, Sun R, Tian Z.
Abstract:BACKGROUND & AIMS:It was reported that alcohol consumption activated the NLRP3 inflammasome in Kupffer cells, leading to mature IL-1β release in alcoholic liver injury; however, how IL-1β promotes liver injury remains unclear.

METHODS:We investigated the role of IL-1β in alcoholic steatohepatitis by using a chronic plus single-binge ethanol consumption mouse model.

RESULTS:Here, liver steatosis was accompanied by notably increased invariant NKT (iNKT) cell numbers and activation, and iNKT-deficient Jα18-/-mice developed less alcohol-induced steatosis, with reduced liver inflammation and neutrophil infiltration. Kupffer cells and IL-1β were required for the hepatic iNKT accumulation, as blocking IL-1β signaling with a recombinant interleukin-1 receptor antagonist (IL-1Ra), depleting Kupffer cells by clodronate liposomes, or specifically silencing IL-1β in Kupffer cells by nanoparticle-encapsulated siRNA obviously inhibited hepatic iNKT cell accumulation and activation as well as amelioration of alcoholic fatty liver, and IL-1β over-expression in hepatocytes was sufficient to compensate for Kupffer cell depletion. Increased gene and protein expression of mature IL-1β correlated with elevated expression of the NLRP3 inflammasome components NLRP3, ASC, and cleaved caspase-1 in Kupffer cells from ethanol-exposed wild-type(WT) mice, and NLRP3 deficiency led to the attenuation of alcoholic steatosis, similarly as Kupffer cell depletion, almost without hepatic NKT cells.

CONCLUSIONS:Kupffer cell-derived IL-1β, produced after alcohol-induced NLRP3 activation, recruits and activates hepatic iNKT cells, subsequently promoting liver inflammation and neutrophil infiltration, and inducing alcoholic liver injury.

 



版权与免责声明:本网页的内容由收集互联网上公开发布的信息整理获得。目的在于传递信息及分享,并不意味着赞同其观点或证实其真实性,也不构成其他建议。仅提供交流平台,不为其版权负责。如涉及侵权,请联系我们及时修改或删除。邮箱:sales@allpeptide.com

返回首页 浙公网安备 33010602009704号;浙ICP备18001318号